Breaking News Instant updates and real-time market news.

2020-08-10 07:46:26 PRTK Paratek Pharmaceuticals $4.57 / +0.075 (+1.67%) 07:46 08/10/20 08/10 07:46 08/10/20 07:46	Paratek Pharmaceuticals expects cash to fund operations through end of 2023 The Company now anticipates the initial BARDA procurement of 2,500 anthrax treatment courses valued at approximately $38 million to occur by the end of 2020 contingent on the completion of the pre-EUA application review by FDA. 2020 R&D and SG&A expense is now expected to be approximately $135 million compared to the prior guidance of $140 million, driven by an increased focus on operational efficiencies and other favorability driven by the COVID-19 pandemic. Excluding the BARDA R&D and onshoring cost reimbursement, R&D and SG&A expense is expected to be modestly lower when compared to 2019. Based upon our current operating plan, which includes estimated NUZYRA U.S. product revenue and cost reimbursement under the BARDA contract, we anticipate that our existing cash, cash equivalents and marketable securities of $186.8 million, as of June 30, 2020, provide for a cash runway through the end of 2023 with a pathway to cash flow break even. This anticipated pathway assumes the Company will be able to fund all company operating expenses, anticipated capital expenditures, and debt service, including repayment in full of the Hercules Loan and Security Agreement.	10 Aug 11 Aug
PRTK Paratek Pharmaceuticals $4.57 / +0.075 (+1.67%) 05/06/20 H.C. Wainwright Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright 04/01/20 H.C. Wainwright Paratek BARDA funding 'kicks off' Nuzyra onshoring, says H.C. Wainwright 03/24/20 H.C. Wainwright Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright 01/08/20 WBB Securities Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities

2020-08-10 07:46:26

PRTK

Paratek Pharmaceuticals

$4.57 / +0.075 (+1.67%)

07:46

08/10/20

08/10

07:46

08/10/20

07:46

Paratek Pharmaceuticals expects cash to fund operations through end of 2023

The Company now anticipates the initial BARDA procurement of 2,500 anthrax treatment courses valued at approximately $38 million to occur by the end of 2020 contingent on the completion of the pre-EUA application review by FDA. 2020 R&D and SG&A expense is now expected to be approximately $135 million compared to the prior guidance of $140 million, driven by an increased focus on operational efficiencies and other favorability driven by the COVID-19 pandemic. Excluding the BARDA R&D and onshoring cost reimbursement, R&D and SG&A expense is expected to be modestly lower when compared to 2019. Based upon our current operating plan, which includes estimated NUZYRA U.S. product revenue and cost reimbursement under the BARDA contract, we anticipate that our existing cash, cash equivalents and marketable securities of $186.8 million, as of June 30, 2020, provide for a cash runway through the end of 2023 with a pathway to cash flow break even. This anticipated pathway assumes the Company will be able to fund all company operating expenses, anticipated capital expenditures, and debt service, including repayment in full of the Hercules Loan and Security Agreement.

10
Aug
11
Aug

PRTK Paratek Pharmaceuticals

$4.57 / +0.075 (+1.67%)

05/06/20 H.C. Wainwright: Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright

04/01/20 H.C. Wainwright: Paratek BARDA funding 'kicks off' Nuzyra onshoring, says H.C. Wainwright

03/24/20 H.C. Wainwright: Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright

01/08/20 WBB Securities: Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities

TODAY'S FREE FLY STORIES

Hot Stocks	PPD trading resumes 16:00 04/14/21 04/14 16:00 04/14/21 16:00 PPD PPD $38.97 / +0.62 (+1.62%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events PPD PPD $38.97 / +0.62 (+1.62%) 15:47 Today PPD trading halted, volatility trading pause 04/13/21 AzurRx BioPharma partners with PPD for clinical trial for niclosamide 04/06/21 AzurRx BioPharma initiates Phase 2 clinical trial of niclosamide 03/24/21 PPD, Clinical Ink team on process for lupus assessment PPD PPD $38.97 / +0.62 (+1.62%) 03/02/21 Barclays PPD initiated with an Overweight at Barclays 03/02/21 Barclays PPD initiated with an Overweight at Barclays 02/25/21 Deutsche Bank PPD price target raised to $39 from $38 at Deutsche Bank 02/25/21 Citi PPD price target raised to $42 from $40 at Citi PPD PPD $38.97 / +0.62 (+1.62%) 02/23/21 PPD sees 2021 adjusted EPS $1.37-$1.45, consensus $1.39 02/23/21 PPD sees Q1 adjusted EPS 30c-32c, consensus 32c 02/23/21 PPD reports Q4 adjusted EPS 39c, consensus 36c 10/27/20 PPD sees Q4 revenue $1.26B-$1.3B, consensus $1.15B 17 Sep PPD PPD $38.97 / +0.62 (+1.62%) 15:51 Today Thermo Fisher near deal to buy PPD for over $15B, WSJ reports 15:49 Today PPD jumps 13% after report of Thermo Fisher takeover talks PPD PPD $38.97 / +0.62 (+1.62%) 03/15/21 Meet AzurRx BioPharma: A Fly exclusive interview with CEO James Sapirstein 04/28/21 PPD - PPD 04/23/21 PPD, Inc.
Recommendations	IQE price target lowered to 80 GBp from 100 GBp at Deutsche Bank » 15:59 04/14/21 04/14 15:59 04/14/21 15:59 IQEPF IQE / + Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research IQEPF IQE / + 03/26/21 Canaccord IQE downgraded to Hold from Speculative Buy at Canaccord 02/09/21 Stifel IQE upgraded to Buy from Hold at Stifel 01/26/21 Deutsche Bank IQE price target raised to 100 GBp from 90 GBp at Deutsche Bank 01/14/21 Barclays IQE price target raised to 70 GBp from 60 GBp at Barclays
Recommendations	LVMH price target raised to EUR 531 from EUR 495 at Deutsche Bank » 15:57 04/14/21 04/14 15:57 04/14/21 15:57 LVMUY LVMH $147.85 / +6.86 (+4.87%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH says 'well-equipped to build upon the hoped-for recovery' 02/22/21 LVMH's Moet Hennessy takes 50% stake in Jay-Z's Armand de Brignac brand 12/31/20 Tiffany holders approve LVMH takeover, deal to close on January 7 10/29/20 LVMH, Tiffany agree to reduced takeover price of $131.50 per share LVMUY LVMH $147.85 / +6.86 (+4.87%) 15:44 Today UBS LVMH price target raised to EUR 667 from EUR 640 at UBS 15:19 Today Morgan Stanley LVMH price target raised to EUR 670 from EUR 625 at Morgan Stanley 15:11 Today RBC Capital LVMH price target raised to EUR 635 from EUR 600 at RBC Capital 15:08 Today JPMorgan LVMH price target raised to EUR 685 from EUR 625 at JPMorgan LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH reports Q1 revenue EUR 13.96B, consensus EUR 12.7B 10/15/20 LVMH reports Q3 revenue EUR 11.96B vs. EUR 13.32B last year 10/15/20 LVMH reports Q3 organic revenue down 7% LVMUY LVMH $147.85 / +6.86 (+4.87%) 02/10/21 Rihanna's Fenty fashion line put on hold, WWD reports 10/28/20 LVMH, Tiffany near deal to lower takeout price to $131.50 from $135, WSJ says 10/27/20 Tiffany seeks around $132 per share from LVMH, Bloomberg reports 10/27/20 Tiffany close to new deal price of $130-$133 per share from LVMH, CNBC says LVMUY LVMH $147.85 / +6.86 (+4.87%) 10/27/20 Fly Intel: Wall Street's top stories for Tuesday
Recommendations	Aixtron price target raised to EUR 25 from EUR 22 at Deutsche Bank » 15:55 04/14/21 04/14 15:55 04/14/21 15:55 AIXXF Aixtron $22.70 / + (+0.00%) Deutsche Bank analyst Uwe… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AIXXF Aixtron $22.70 / + (+0.00%) 15:14 Today Barclays Aixtron price target raised to EUR 24 from EUR 23 at Barclays 03/09/21 Berenberg Aixtron price target raised to EUR 18 from EUR 11 at Berenberg 02/26/21 Barclays Aixtron price target raised to EUR 23 from EUR 15.50 at Barclays 02/19/21 Deutsche Bank Aixtron price target raised to EUR 22 from EUR 14 at Deutsche Bank
Conference/Events	Affimed to hold a conference call » 15:55 04/14/21 04/14 15:55 04/14/21 15:55 AFMD Affimed $10.28 / +0.41 (+4.16%) Management discusses the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events AFMD Affimed $10.28 / +0.41 (+4.16%) 04/12/21 Affimed highlights potential of Innate Cell Engager AFM24 at AACR 04/09/21 Affimed N.V. announces clinical data from cbNK cells with AFM13 study 03/31/21 Affimed N.V,'s IND application for antitumor combination granted FDA clearance. 03/10/21 Affimed N.V. to continue enrollment in AFM13 study after positive interim data AFMD Affimed $10.28 / +0.41 (+4.16%) 04/12/21 BMO Capital Affimed price target raised to $15 from $12 at BMO Capital 03/30/21 Credit Suisse Affimed N.V. initiated with an Outperform at Credit Suisse 03/30/21 Credit Suisse Affimed N.V. initiated with an Outperform at Credit Suisse 03/24/21 Wells Fargo Affimed N.V. price target raised to $15 from $10 at Wells Fargo 13 Jan AFMD Affimed $10.28 / +0.41 (+4.16%) 04/09/21 Fly Intel: Wall Street's top stories at midday 04/09/21 Fly Intel: Pre-market Movers 03/10/21 Fly Intel: Wall Street's top stories for Wednesday 03/10/21 Fly Intel: Wall Street's top stories at midday 16:05 Today Affimed - AFMD 04/15/21 Affimed N.V. - AFMD

Recommendations	Lovesac price target raised to $77 from $65 at Canaccord » 15:54 04/14/21 04/14 15:54 04/14/21 15:54 LOVE Lovesac $62.39 / -3.06 (-4.68%) Canaccord analyst Maria… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LOVE Lovesac $62.39 / -3.06 (-4.68%) 11/12/20 Lovesac, Best Buy launch joint online shopping experience LOVE Lovesac $62.39 / -3.06 (-4.68%) 13:27 Today Craig-Hallum Lovesac price target raised to $85 from $50 at Craig-Hallum 04/13/21 Roth Capital Lovesac price target raised to $80 from $50 at Roth Capital 04/09/21 BTIG Lovesac price target raised to $77 from $62 at BTIG 01/08/21 BTIG Lovesac price target raised to $62 from $49 at BTIG LOVE Lovesac $62.39 / -3.06 (-4.68%) 07:10 Today Lovesac reports Q4 adjusted EPS $1.37, consensus 58c 12/09/20 Lovesac reports Q3 EPS 16c, consensus (88c) LOVE Lovesac $62.39 / -3.06 (-4.68%) 08:59 Today Fly Intel: Pre-market Movers 12/09/20 Fly Intel: Pre-market Movers 08:30 Today Lovesac - LOVE
Recommendations	Deutsche Post price target raised to EUR 62 from EUR 54 at Deutsche Bank » 15:54 04/14/21 04/14 15:54 04/14/21 15:54 DPSGY Deutsche Post $58.87 / +0.925 (+1.60%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings DPSGY Deutsche Post $58.87 / +0.925 (+1.60%) 15:15 Today Barclays Deutsche Post price target raised to EUR 58 from EUR 52 at Barclays 04/12/21 UBS Deutsche Post price target raised to EUR 52.50 from EUR 48 at UBS 04/12/21 JPMorgan Deutsche Post price target raised to EUR 68.47 from EUR 55.96 at JPMorgan 03/16/21 Berenberg Deutsche Post price target raised to EUR 53 from EUR 51 at Berenberg DPSGY Deutsche Post $58.87 / +0.925 (+1.60%) 04/09/21 Deutsche Post sees 2021 EBIT 'significantly above' EUR 5.6B
Recommendations	VAT Group price target raised to CHF 280 from CHF 240 at Deutsche Bank » 15:53 04/14/21 04/14 15:53 04/14/21 15:53 VACNY VAT Group $31.05 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research VACNY VAT Group $31.05 / + (+0.00%) 15:09 Today JPMorgan VAT Group price target raised to CHF 260 from CHF 165 at JPMorgan 04/09/21 UBS VAT Group price target raised to CHF 300 from CHF 280 at UBS 01/12/21 Deutsche Bank VAT Group price target raised to CHF 225 from CHF 175 at Deutsche Bank 01/12/21 UBS VAT Group price target raised to CHF 255 from CHF 207 at UBS
Conference/Events	HP Enterprise to hold a conference call » 15:52 04/14/21 04/14 15:52 04/14/21 15:52 HPE HP Enterprise $15.80 / +0.13 (+0.83%) Conference call to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HPE HP Enterprise $15.80 / +0.13 (+0.83%) 04/12/21 DOE's LANL expands collaboration with HP Enterprise on new supercomputer design 03/31/21 HP Enterprise announces plan to add 150 new technologist jobs in Ireland 03/25/21 Meg Whitman, Mark Tatum join GM's Board of Directors 01/27/21 HP Enterprise to build $35M+ supercomputer for NCAR HPE HP Enterprise $15.80 / +0.13 (+0.83%) 04/08/21 Morgan Stanley HP Enterprise price target raised to $17 from $15.50 at Morgan Stanley 03/26/21 JPMorgan HP Enterprise price target raised to $18 from $17 at JPMorgan 03/10/21 Fly Intel: Top five analyst upgrades 03/10/21 Daiwa HP Enterprise upgraded to Outperform from Neutral at Daiwa HPE HP Enterprise $15.80 / +0.13 (+0.83%) 03/02/21 HP Enterprise raises FY21 adjusted EPS view to $1.70-$1.88, consensus $1.67 03/02/21 HP Enterprise sees Q2 adjusted EPS 38c-44c, consensus 38c 03/02/21 HP Enterprise reports Q1 adjusted EPS 52c, consensus 41c 12/01/20 HP Enterprise sees Q1 revenue down mid-single digits from Q4 HPE HP Enterprise $15.80 / +0.13 (+0.83%) 03/10/21 Novartis downgrade, HP Enterprise upgrade among today's top calls on Wall Street 12/02/20 Fly Intel: Wall Street's top stories for Wednesday 12/02/20 Fly Intel: Wall Street's top stories at midday 12/01/20 Fly Intel: After-Hours Movers 11:00 Today Hewlett Packard Enterprise Co. HPE HP Enterprise $15.80 / +0.13 (+0.83%) 03/12/21 Early notable gainers among liquid option names on March 12th 12/01/20 Hewlett Packard Enterprise options imply 9.8% move in share price post-earnings 11/10/20 Hewlett Packard Enterprise put volume heavy and directionally bearish
Periodicals	Thermo Fisher near deal to buy PPD for over $15B, WSJ reports » 15:51 04/14/21 04/14 15:51 04/14/21 15:51 PPD PPD $39.07 / +0.72 (+1.88%) , TMO Thermo Fisher $476.14 / -8.67 (-1.79%) Thermo Fisher Scientific… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events PPD TMO PPD PPD $39.07 / +0.72 (+1.88%) 15:47 Today PPD trading halted, volatility trading pause 04/13/21 AzurRx BioPharma partners with PPD for clinical trial for niclosamide 04/06/21 AzurRx BioPharma initiates Phase 2 clinical trial of niclosamide 03/24/21 PPD, Clinical Ink team on process for lupus assessment TMO Thermo Fisher $476.14 / -8.67 (-1.79%) 04/12/21 Thermo Fisher: FDA grants EUA for high-throughput COVID-19 Test 03/24/21 Thermo Fisher to offer integrated COVID-19 testing to U.S. school districts 03/24/21 Thermo Fisher announces launch of in-air SARS-CoV-2 surveillance solution 03/10/21 Thermo Fisher investing over $600M to expand bioprocessing production PPD TMO PPD PPD $39.07 / +0.72 (+1.88%) 03/02/21 Barclays PPD initiated with an Overweight at Barclays 03/02/21 Barclays PPD initiated with an Overweight at Barclays 02/25/21 Deutsche Bank PPD price target raised to $39 from $38 at Deutsche Bank 02/25/21 Citi PPD price target raised to $42 from $40 at Citi TMO Thermo Fisher $476.14 / -8.67 (-1.79%) 03/29/21 UBS Thermo Fisher price target lowered to $560 from $588 at UBS 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc 03/02/21 Barclays Thermo Fisher initiated with an Overweight at Barclays PPD TMO PPD PPD $39.07 / +0.72 (+1.88%) 02/23/21 PPD sees 2021 adjusted EPS $1.37-$1.45, consensus $1.39 02/23/21 PPD sees Q1 adjusted EPS 30c-32c, consensus 32c 02/23/21 PPD reports Q4 adjusted EPS 39c, consensus 36c 10/27/20 PPD sees Q4 revenue $1.26B-$1.3B, consensus $1.15B TMO Thermo Fisher $476.14 / -8.67 (-1.79%) 02/01/21 Thermo Fisher sees FY21 EPS $21.62, consensus $20.74 02/01/21 Thermo Fisher reports Q4 adjusted EPS $7.09, consensus $6.56 12/01/20 Thermo Fisher raises FY20 adjusted EPS view to $19.17, consensus $18.34 10/21/20 Thermo Fisher sees FY20 EPS $18.27, consensus $15.92 17 Sep PPD TMO PPD PPD $39.07 / +0.72 (+1.88%) 15:49 Today PPD jumps 13% after report of Thermo Fisher takeover talks TMO Thermo Fisher $476.14 / -8.67 (-1.79%) 15:49 Today PPD jumps 13% after report of Thermo Fisher takeover talks 15:48 Today Thermo Fisher near deal to buy drug-testing company PPD for over $15B, WSJ says 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports PPD TMO PPD PPD $39.07 / +0.72 (+1.88%) 03/15/21 Meet AzurRx BioPharma: A Fly exclusive interview with CEO James Sapirstein TMO Thermo Fisher $476.14 / -8.67 (-1.79%) 02/01/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 10/21/20 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/28/21 PPD - PPD 04/29/21 Thermo Fisher - TMO 04/23/21 PPD, Inc. 05/19/21 Thermo Fisher Scientific Inc.

On The Fly	#SocialStocks: Facebook removes 16,000 trading groups with fake product reviews » 15:50 04/14/21 04/14 15:50 04/14/21 15:50 TWTR Twitter $70.03 / -2.42 (-3.34%) , FB Facebook $303.67 / -6.27 (-2.02%) , NLSN Nielsen $25.34 / +0.07 (+0.28%) , AAPL Apple $132.15 / -2.26 (-1.68%) , SNAP Snap $61.93 / -0.51 (-0.82%) , SPT Sprout Social $62.25 / -0.55 (-0.88%) Welcome to… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TWTR FB NLSN AAPL SNAP SPT TWTR Twitter $70.03 / -2.42 (-3.34%) 04/12/21 Twitter building team in Ghana to establish Africa presence 04/08/21 Twitter integrates Nielsen's cross-media solutions into video ad platform 03/23/21 Twitter welcomes Reshuffle team amid API improvements 03/11/21 Super League Gaming to acquire Mobcrush, terms not disclosed FB Facebook $303.67 / -6.27 (-2.02%) 04/09/21 Facebook removes 16,000 groups trading fake reviews, says U.K.'s CMA 04/09/21 Facebook to convert part of Menlo Park HQ into vaccination site 04/08/21 Facebook tweets today's technical glitch was 'quickly resolved' 04/05/21 Facebook announces new ad solution, Dynamic Ads for Streaming NLSN Nielsen $25.34 / +0.07 (+0.28%) 04/08/21 Twitter integrates Nielsen's cross-media solutions into video ad platform 03/23/21 Nielsen appoints Sandra Sims-Williams as Chief Diversity Officer 03/16/21 Nielsen Audio, Spanish Broadcasting System sign multi-year agreement 03/01/21 Roku to acquire Nielsen's video advertising business AAPL Apple $132.15 / -2.26 (-1.68%) 04/13/21 Apple confirms plans for 'Spring Loaded' event on April 20 04/13/21 Eli Lilly announces Diogo Rau as chief information, digital officer 04/12/21 Apple Mac sales implied up 65% vs. 22% consensus, Gene Munster says 04/02/21 Apple adds over 30 titles to Arcade, bringing total to over 180 games SNAP Snap $61.93 / -0.51 (-0.82%) 03/17/21 Snap acquires Fit Analytics, terms not disclosed 03/03/21 Snap CEO sells 1.54M shares of common stock 02/23/21 Snap sees gross margins continuing to expand in 2021 02/23/21 Snap says Map feature reaches over 250M monthly active users SPT Sprout Social $62.25 / -0.55 (-0.88%) 10/20/20 Sprout Social announces integration with Glassdoor TWTR FB NLSN AAPL SNAP SPT TWTR Twitter $70.03 / -2.42 (-3.34%) 07:22 Today Wedbush Twitter assumed with a Neutral, $75 price target at Wedbush 04/13/21 Wedbush Twitter assumed with a Neutral at Wedbush 04/05/21 Evercore ISI Twitter assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Twitter initiated with a Peer Perform at Wolfe Research FB Facebook $303.67 / -6.27 (-2.02%) 04/13/21 Wedbush Facebook assumed with Neutral at Wedbush, cites privacy risk 04/13/21 Wedbush Facebook assumed at Neutral from Outperform at Wedbush 04/05/21 Evercore ISI Facebook assumed with an Outperform at Evercore ISI 03/31/21 Wolfe Research Facebook initiated with an Outperform at Wolfe Research NLSN Nielsen $25.34 / +0.07 (+0.28%) 03/19/21 Deutsche Bank Nielsen price target raised to $29 from $18 at Deutsche Bank 03/12/21 JPMorgan Nielsen reinstated with an Overweight at JPMorgan 03/04/21 Fly Intel: Top five analyst upgrades 03/04/21 BMO Capital Nielsen upgraded to Outperform from Market Perform at BMO Capital AAPL Apple $132.15 / -2.26 (-1.68%) 06:40 Today Evercore ISI Apple added to Tactical Outperform list at Evercore ISI 04/13/21 Wedbush Facebook assumed with Neutral at Wedbush, cites privacy risk 04/12/21 Canaccord Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem 04/09/21 Citi Citi tells investors to focus on Apple's capital deployment, iPhone gains SNAP Snap $61.93 / -0.51 (-0.82%) 04/13/21 Wedbush Snap upgraded to Outperform upon assumption at Wedbush 04/13/21 Wedbush Snap assumed at Outperform from Neutral at Wedbush 04/06/21 Atlantic Equities Snap upgraded to Overweight from Neutral at Atlantic Equities 04/05/21 Evercore ISI Snap assumed with an Outperform at Evercore ISI SPT Sprout Social $62.25 / -0.55 (-0.88%) 04/09/21 Baird Sprout Social taking advantage of social commerce opportunity, says Baird 03/24/21 Canaccord Sprout Social has several levers to durable growth, says Canaccord 03/15/21 Baird Sprout Social elevated to bullish Fresh Pick at Baird 02/24/21 KeyBanc Sprout Social price target raised to $81 from $55 at KeyBanc TWTR FB NLSN AAPL SNAP SPT TWTR Twitter $70.03 / -2.42 (-3.34%) 02/25/21 Twitter announces three long-term goals, aims to double sales in 2023 02/09/21 Twitter sees Q1 revenue $940M-$1.04B, consensus $965.14M 02/09/21 Twitter reports Q4 adjusted EPS 38c, consensus 31c 02/09/21 Notable companies reporting after market close FB Facebook $303.67 / -6.27 (-2.02%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/27/21 Facebook reports Q4 EPS $3.88, consensus $3.22 01/27/21 Notable companies reporting after market close 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 NLSN Nielsen $25.34 / +0.07 (+0.28%) 02/25/21 Nielsen sees FY21 adjusted EPS $1.43-$1.54, consensus $1.66 02/25/21 Nielsen reports Q4 adjusted EPS 53c, consensus 46c 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open AAPL Apple $132.15 / -2.26 (-1.68%) 04/13/21 Fly Intel: What to watch in first round of big bank earnings reports 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations SNAP Snap $61.93 / -0.51 (-0.82%) 02/04/21 Snap sees Q1 revenue $720M-$740M, consensus $704.57M 02/04/21 Snap reports Q4 adjusted EPS 9c, consensus 7c 02/04/21 Notable companies reporting after market close 10/20/20 Snap says 47%-50% year-over-year revenue growth in Q4 'attainable' SPT Sprout Social $62.25 / -0.55 (-0.88%) 02/23/21 Sprout Social sees FY21 EPS (40c)-(37c), consensus (40c) 02/23/21 Sprout Social sees Q1 EPS (11c)-(10c), consensus (12c) 02/23/21 Sprout Social reports Q4 EPS (6c), consensus (11c) 11/09/20 Sprout Social raises FY20 EPS view to (45c)-(44c) from (57c)-(50c) 13 Aug TWTR FB NLSN AAPL SNAP TWTR Twitter $70.03 / -2.42 (-3.34%) 04/07/21 Twitter has previously discussed $4B acquisition of Clubhouse, Bloomberg reports 04/07/21 Twitter discussed $4B takeover deal for Clubhouse, Bloomberg says 04/07/21 Twitter says eventually users may complete shopping on service, Reuters reports 04/05/21 Justice Thomas suggests utility-like regulation for some tech, CNBC says FB Facebook $303.67 / -6.27 (-2.02%) 04/08/21 Facebook experiencing technical problems, Bloomberg reports 04/08/21 Facebook not planning to notify users impacted by data leak, Reuters reports 04/07/21 Facebook didn't hire Black employees because of 'culture fit,' BI reports 04/07/21 Facebook, Google donated to GOP group that pushes voter supression laws, BI says NLSN Nielsen $25.34 / +0.07 (+0.28%) 10/27/20 Nielsen in talks with PE group about $2.9B sale of consumer goods unit, FT says AAPL Apple $132.15 / -2.26 (-1.68%) 06:01 Today Kuo: 2022 iPhone lineup to feature 6.1'', 6.7'' devices, MacRumors reports 04/13/21 Apple's April 20 event prematurely revelead by Siri, MacRumors reports 04/12/21 Apple faces supply constraints with iPad Pros, Bloomberg reports 04/11/21 Apple agrees to testify before Senate on app store concerns, Reuters reports SNAP Snap $61.93 / -0.51 (-0.82%) 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 03/30/21 Snap developing new Spectacles with augmented reality, Information reports 03/05/21 Reddit hires Drew Vollero as CFO ahead of eventual IPO, NY Times reports 02/16/21 ByteDance looks to list Douyin in NY as Biden sets new mood, SCMP reports TWTR FB NLSN AAPL SNAP SPT TWTR Twitter $70.03 / -2.42 (-3.34%) 10:14 Today Alphabet coverage assumption, Facebook downgrade among top calls on Wall Street 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 04/07/21 #SocialStocks: AR glasses seen as future of tech FB Facebook $303.67 / -6.27 (-2.02%) 10:14 Today Alphabet coverage assumption, Facebook downgrade among top calls on Wall Street 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street NLSN Nielsen $25.34 / +0.07 (+0.28%) 03/03/21 KeyBanc says buy Roku on video monetization following Nielsen deal 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 03/01/21 Fly Intel: After-Hours Movers 11/02/20 Fly Intel: Wall Street's top stories for Monday AAPL Apple $132.15 / -2.26 (-1.68%) 10:14 Today Alphabet coverage assumption, Facebook downgrade among top calls on Wall Street 04/13/21 Game On: GameStop may be looking for new CEO 04/12/21 Tesla, Chipotle upgrades among today's top calls on Wall Street 04/11/21 On the Fly: The Week in SPAC News SNAP Snap $61.93 / -0.51 (-0.82%) 10:14 Today Alphabet coverage assumption, Facebook downgrade among top calls on Wall Street 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/06/21 Fly Intel: Pre-market Movers SPT Sprout Social $62.25 / -0.55 (-0.88%) 03/17/21 #SocialStocks: Facebook dabbles in news, publishing 02/24/21 #SocialStocks: Snap shares advance following first investor day 02/23/21 Fly Intel: After-Hours Movers 01/20/21 #SocialStocks: Facebook could be in focus under new administration 04/22/21 Digital Media 05/24/21 Global Technology, Media & Communications Virtual Conference 04/22/21 Snap - SNAP 04/28/21 Apple - AAPL 04/28/21 Facebook - FB 04/29/21 Twitter - TWTR 05/04/21 Sprout Social - SPT 05/12/21 Sprout Social 05/25/21 Nielsen Holdings plc 05/26/21 Sprout Social, Inc. 05/26/21 Facebook Inc. 05/27/21 Twitter, Inc. TWTR FB NLSN AAPL SNAP TWTR Twitter $70.03 / -2.42 (-3.34%) 04/08/21 Twitter call volume above normal and directionally bullish 04/07/21 Unusual call flow in option market yesterday 04/06/21 Twitter call volume above normal and directionally bullish 04/06/21 Early notable gainers among liquid option names on April 6th FB Facebook $303.67 / -6.27 (-2.02%) 03/18/21 Facebook call volume above normal and directionally bullish 02/16/21 Facebook call volume above normal and directionally bullish 01/27/21 Facebook options imply 11.6% move in share price post-earnings 01/15/21 Facebook call volume above normal and directionally bullish NLSN Nielsen $25.34 / +0.07 (+0.28%) 03/04/21 Early notable gainers among liquid option names on March 4th 03/02/21 Early notable gainers among liquid option names on March 2nd 12/04/20 Unusual call flow in option market yesterday 12/03/20 Bulls tune in to calls on Nielson Holdings AAPL Apple $132.15 / -2.26 (-1.68%) 08:55 Today Notable open interest changes for April 14th 04/13/21 Notable open interest changes for April 13th 04/12/21 Notable open interest changes for April 12th 04/09/21 Notable open interest changes for April 9th SNAP Snap $61.93 / -0.51 (-0.82%) 04/12/21 Notable open interest changes for April 12th 04/08/21 Snap Inc. call buyer realizes 13% same-day gains 04/06/21 Unusually active option classes on open April 6th 03/26/21 Notable open interest changes for March 26th
Recommendations	ASML price target raised to EUR 500 from EUR 425 at Deutsche Bank » 15:50 04/14/21 04/14 15:50 04/14/21 15:50 ASML ASML $629.97 / +0.655 (+0.10%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals ASML ASML $629.97 / +0.655 (+0.10%) 03/03/21 ASML says SMIC purchase agreement disclosure not material event ASML ASML $629.97 / +0.655 (+0.10%) 15:15 Today Barclays ASML price target raised to EUR 620 from EUR 525 at Barclays 03/22/21 Cowen ASML upgraded to Outperform from Market Perform at Cowen 02/02/21 JPMorgan ASML price target raised to EUR 534 from EUR 472 at JPMorgan 02/02/21 JPMorgan ASML price target raised to $640 from $524 at JPMorgan ASML ASML $629.97 / +0.655 (+0.10%) 01/20/21 ASML sees Q1 net sales EUR 3.9B-EUR 4.1B, gross margin 50%-51% 01/20/21 ASML reports Q4 EPS EUR 3.23 vs. EUR 2.54 last quarter ASML ASML $629.97 / +0.655 (+0.10%) 11/13/20 TSMC places EUV equipment orders with ASML for 2021, DigiTimes reports
Periodicals	PPD jumps 13% after report of Thermo Fisher takeover talks 15:49 04/14/21 04/14 15:49 04/14/21 15:49 PPD PPD $39.11 / +0.76 (+1.98%) , TMO Thermo Fisher $477.17 / -7.64 (-1.58%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events PPD TMO PPD PPD $39.11 / +0.76 (+1.98%) 15:47 Today PPD trading halted, volatility trading pause 04/13/21 AzurRx BioPharma partners with PPD for clinical trial for niclosamide 04/06/21 AzurRx BioPharma initiates Phase 2 clinical trial of niclosamide 03/24/21 PPD, Clinical Ink team on process for lupus assessment TMO Thermo Fisher $477.17 / -7.64 (-1.58%) 04/12/21 Thermo Fisher: FDA grants EUA for high-throughput COVID-19 Test 03/24/21 Thermo Fisher to offer integrated COVID-19 testing to U.S. school districts 03/24/21 Thermo Fisher announces launch of in-air SARS-CoV-2 surveillance solution 03/10/21 Thermo Fisher investing over $600M to expand bioprocessing production PPD TMO PPD PPD $39.11 / +0.76 (+1.98%) 03/02/21 Barclays PPD initiated with an Overweight at Barclays 03/02/21 Barclays PPD initiated with an Overweight at Barclays 02/25/21 Deutsche Bank PPD price target raised to $39 from $38 at Deutsche Bank 02/25/21 Citi PPD price target raised to $42 from $40 at Citi TMO Thermo Fisher $477.17 / -7.64 (-1.58%) 03/29/21 UBS Thermo Fisher price target lowered to $560 from $588 at UBS 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc 03/02/21 Barclays Thermo Fisher initiated with an Overweight at Barclays PPD TMO PPD PPD $39.11 / +0.76 (+1.98%) 02/23/21 PPD sees 2021 adjusted EPS $1.37-$1.45, consensus $1.39 02/23/21 PPD sees Q1 adjusted EPS 30c-32c, consensus 32c 02/23/21 PPD reports Q4 adjusted EPS 39c, consensus 36c 10/27/20 PPD sees Q4 revenue $1.26B-$1.3B, consensus $1.15B TMO Thermo Fisher $477.17 / -7.64 (-1.58%) 02/01/21 Thermo Fisher sees FY21 EPS $21.62, consensus $20.74 02/01/21 Thermo Fisher reports Q4 adjusted EPS $7.09, consensus $6.56 12/01/20 Thermo Fisher raises FY20 adjusted EPS view to $19.17, consensus $18.34 10/21/20 Thermo Fisher sees FY20 EPS $18.27, consensus $15.92 17 Sep TMO TMO Thermo Fisher $477.17 / -7.64 (-1.58%) 15:48 Today Thermo Fisher near deal to buy drug-testing company PPD for over $15B, WSJ says 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports PPD TMO PPD PPD $39.11 / +0.76 (+1.98%) 03/15/21 Meet AzurRx BioPharma: A Fly exclusive interview with CEO James Sapirstein TMO Thermo Fisher $477.17 / -7.64 (-1.58%) 02/01/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 10/21/20 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/28/21 PPD - PPD 04/29/21 Thermo Fisher - TMO 04/23/21 PPD, Inc. 05/19/21 Thermo Fisher Scientific Inc.
Recommendations	BE Semiconductor price target raised to EUR 72 from EUR 60 at Deutsche Bank » 15:49 04/14/21 04/14 15:49 04/14/21 15:49 BESIY BE Semiconductor $91.70 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BESIY BE Semiconductor $91.70 / + (+0.00%) 03/09/21 Deutsche Bank BE Semiconductor price target raised to EUR 60 from EUR 50 at Deutsche Bank 01/12/21 Deutsche Bank BE Semiconductor price target raised to EUR 50 from EUR 40 at Deutsche Bank 01/08/21 Berenberg BE Semiconductor price target raised to EUR 60 from EUR 46.50 at Berenberg 10/26/20 Deutsche Bank BE Semiconductor price target raised to EUR 40 from EUR 35 at Deutsche Bank
Periodicals	Thermo Fisher near deal to buy drug-testing company PPD for over $15B, WSJ says 15:48 04/14/21 04/14 15:48 04/14/21 15:48 TMO Thermo Fisher $477.15 / -7.66 (-1.58%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TMO Thermo Fisher $477.15 / -7.66 (-1.58%) 04/12/21 Thermo Fisher: FDA grants EUA for high-throughput COVID-19 Test 03/24/21 Thermo Fisher to offer integrated COVID-19 testing to U.S. school districts 03/24/21 Thermo Fisher announces launch of in-air SARS-CoV-2 surveillance solution 03/10/21 Thermo Fisher investing over $600M to expand bioprocessing production TMO Thermo Fisher $477.15 / -7.66 (-1.58%) 03/29/21 UBS Thermo Fisher price target lowered to $560 from $588 at UBS 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc 03/02/21 Barclays Thermo Fisher initiated with an Overweight at Barclays TMO Thermo Fisher $477.15 / -7.66 (-1.58%) 02/01/21 Thermo Fisher sees FY21 EPS $21.62, consensus $20.74 02/01/21 Thermo Fisher reports Q4 adjusted EPS $7.09, consensus $6.56 12/01/20 Thermo Fisher raises FY20 adjusted EPS view to $19.17, consensus $18.34 10/21/20 Thermo Fisher sees FY20 EPS $18.27, consensus $15.92 TMO Thermo Fisher $477.15 / -7.66 (-1.58%) 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports TMO Thermo Fisher $477.15 / -7.66 (-1.58%) 02/01/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 10/21/20 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/29/21 Thermo Fisher - TMO 05/19/21 Thermo Fisher Scientific Inc.

Recommendations	Yara price target raised to NOK 465 from NOK 450 at UBS » 15:48 04/14/21 04/14 15:48 04/14/21 15:48 YARIY Yara $25.30 / +0.15 (+0.60%) UBS analyst Andrew Stott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research YARIY Yara $25.30 / +0.15 (+0.60%) 04/13/21 Berenberg Yara downgraded to Hold from Buy at Berenberg 04/07/21 Nordea Yara downgraded to Sell from Hold at Nordea 03/30/21 Pareto Yara downgraded to Hold from Buy at Pareto 03/26/21 Deutsche Bank Yara price target raised to NOK 450 from NOK 420 at Deutsche Bank
Recommendations	ASM International price target raised to EUR 300 from EUR 250 at Deutsche Bank » 15:48 04/14/21 04/14 15:48 04/14/21 15:48 ASMIY ASM International / + Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events ASMIY ASM International / + 15:14 Today Barclays ASM International price target raised to EUR 295 from EUR 250 at Barclays 03/30/21 Morgan Stanley ASM International price target raised to EUR 240 from EUR 154 at Morgan Stanley 03/02/21 Deutsche Bank ASM International price target raised to EUR 250 from EUR 210 at Deutsche Bank 03/01/21 Barclays ASM International price target raised to EUR 250 from EUR 210 at Barclays 04/21/21 ASM International - ASMIY
Recommendations	Wacker Chemie price target raised to EUR 140 from EUR 130 at UBS » 15:48 04/14/21 04/14 15:48 04/14/21 15:48 WKCMF Wacker Chemie $153.25 / +5.92 (+4.02%) UBS analyst Patrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research WKCMF Wacker Chemie $153.25 / +5.92 (+4.02%) 03/29/21 Barclays Wacker Chemie initiated with an Overweight at Barclays 03/25/21 UBS Wacker Chemie price target lowered to EUR 130 from EUR 140 at UBS 03/18/21 AlphaValue Wacker Chemie upgraded to Add from Reduce at AlphaValue 02/16/21 Citi Wacker Chemie price target raised to EUR 90 from EUR 84 at Citi
Recommendations	Victrex price target raised to 1,830 GBp from 1,750 GBp at UBS » 15:47 04/14/21 04/14 15:47 04/14/21 15:47 VTXPF Victrex $30.85 / + (+0.00%) UBS analyst Andrew Stott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VTXPF Victrex $30.85 / + (+0.00%) 04/01/21 Stifel Victrex upgraded to Buy from Hold at Stifel 03/30/21 Exane BNP Paribas Victrex upgraded to Outperform from Neutral at Exane BNP Paribas 03/30/21 Citi Victrex upgraded to Neutral from Sell at Citi 03/30/21 Exane BNP Paribas Victrex upgraded to Outperform from Neutral at Exane BNP Paribas
Conference/Events	Rackspace Technology to host business news update conference call » 15:47 04/14/21 04/14 15:47 04/14/21 15:47 RXT Rackspace Technology $25.53 / +0.46 (+1.83%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 02/18/21 Rackspace Technology drops 8% to $22.80 after FY21 EPS view misses estimates 01/19/21 Rackspace Technology enters partnership with SNP Schneider-Neureither & Partner 12/03/20 Rackspace reports achieving AWS Travel and Hospitality Competency status 12/03/20 Rackspace to support launch of Professional Services in AWS marketplace RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 04/01/21 William Blair William Blair starts Rackspace with Outperform, sees 30% upside 03/31/21 William Blair Rackspace Technology initiated with an Outperform at William Blair 01/25/21 Oppenheimer Rackspace Technology initiated with an Outperform at Oppenheimer 09/01/20 BMO Capital Rackspace Technology price target raised to $25 from $23 at BMO Capital RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 02/18/21 Rackspace Technology sees FY21 EPS 95c-$1.05, consensus $1.11 02/18/21 Rackspace Technology reports Q4 EPS 26c, consensus 23c 11/10/20 Rackspace Technology sees FY20 EPS 79c-81c, consensus 79c 11/10/20 Rackspace Technology reports Q3 EPS 19c, consensus 18c 05 Aug RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 03/19/21 Rackspace change-in-control plan worth noting, Dealreporter says RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/19/21 Fly Intel: Pre-market Movers 02/18/21 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 05/12/21 Rackspace Technology, Inc. RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 03/19/21 Unusually active option classes on open March 19th 12/08/20 Largest borrow rate increases among liquid names

Hot Stocks	PPD trading halted, volatility trading pause 15:47 04/14/21 04/14 15:47 04/14/21 15:47 PPD PPD $39.16 / +0.81 (+2.11%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events PPD PPD $39.16 / +0.81 (+2.11%) 04/13/21 AzurRx BioPharma partners with PPD for clinical trial for niclosamide 04/06/21 AzurRx BioPharma initiates Phase 2 clinical trial of niclosamide 03/24/21 PPD, Clinical Ink team on process for lupus assessment 02/18/21 PPD awarded US Army study to help develop PTSD drugs PPD PPD $39.16 / +0.81 (+2.11%) 03/02/21 Barclays PPD initiated with an Overweight at Barclays 03/02/21 Barclays PPD initiated with an Overweight at Barclays 02/25/21 Deutsche Bank PPD price target raised to $39 from $38 at Deutsche Bank 02/25/21 Citi PPD price target raised to $42 from $40 at Citi PPD PPD $39.16 / +0.81 (+2.11%) 02/23/21 PPD sees 2021 adjusted EPS $1.37-$1.45, consensus $1.39 02/23/21 PPD sees Q1 adjusted EPS 30c-32c, consensus 32c 02/23/21 PPD reports Q4 adjusted EPS 39c, consensus 36c 10/27/20 PPD sees Q4 revenue $1.26B-$1.3B, consensus $1.15B 17 Sep PPD PPD $39.16 / +0.81 (+2.11%) 03/15/21 Meet AzurRx BioPharma: A Fly exclusive interview with CEO James Sapirstein 04/28/21 PPD - PPD 04/23/21 PPD, Inc.
Recommendations	Teleperformance price target raised to EUR 370 from EUR 340 at UBS » 15:47 04/14/21 04/14 15:47 04/14/21 15:47 TLPFY Teleperformance $198.77 / +3.83 (+1.96%) UBS analyst Bilal Aziz… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLPFY Teleperformance $198.77 / +3.83 (+1.96%) 04/13/21 Morgan Stanley Teleperformance price target raised to EUR 370 from EUR 350 at Morgan Stanley 04/13/21 JPMorgan Teleperformance price target raised to EUR 370 from EUR 340 at JPMorgan 04/13/21 AlphaValue Teleperformance upgraded to Add from Reduce at AlphaValue 03/17/21 Morgan Stanley Teleperformance price target raised to EUR 350 from EUR 340 at Morgan Stanley
Recommendations	Symrise price target raised to EUR 121 from EUR 118 at UBS » 15:46 04/14/21 04/14 15:46 04/14/21 15:46 SYIEY Symrise $32.58 / +1.1 (+3.49%) UBS analyst Geoff Haire… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research SYIEY Symrise $32.58 / +1.1 (+3.49%) 11/23/20 Sensient to sell fragrance business to Symrise, terms not disclosed SYIEY Symrise $32.58 / +1.1 (+3.49%) 03/12/21 Berenberg Symrise price target lowered to EUR 106 from EUR 109 at Berenberg 03/11/21 DZ Bank Symrise upgraded to Hold from Sell at DZ Bank 03/10/21 JPMorgan Symrise price target lowered to EUR 90 from EUR 98 at JPMorgan 01/18/21 Morgan Stanley Symrise downgraded to Underweight from Equal Weight at Morgan Stanley
Recommendations	Schaeffler price target raised to EUR 8.50 from EUR 6.50 at Deutsche Bank » 15:46 04/14/21 04/14 15:46 04/14/21 15:46 SCFLF Schaeffler $9.65 / + (+0.00%) Deutsche Bank analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SCFLF Schaeffler $9.65 / + (+0.00%) 03/22/21 JPMorgan Schaeffler price target raised to EUR 9 from EUR 8 at JPMorgan 03/09/21 Morgan Stanley Schaeffler price target raised to EUR 5.30 from EUR 5.10 at Morgan Stanley 01/27/21 Berenberg Schaeffler price target raised to EUR 7.90 from EUR 7.20 at Berenberg 01/26/21 UBS Schaeffler price target raised to EUR 6.60 from EUR 6.30 at UBS
Recommendations	Serco Group price target raised to 165 GBp from 155 GBp at UBS » 15:46 04/14/21 04/14 15:46 04/14/21 15:46 SECCF Serco Group $1.94 / + (+0.00%) UBS analyst Rory McKenzie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SECCF Serco Group $1.94 / + (+0.00%) 03/01/21 Barclays Serco Group price target raised to 170 GBp from 150 GBp at Barclays 12/18/20 RBC Capital Serco Group price target lowered to 170 GBp from 180 GBp at RBC Capital 12/18/20 Berenberg Serco Group price target lowered to 185 GBp from 195 GBp at Berenberg 12/10/20 Barclays Serco Group price target lowered to 150 GBp from 165 GBp at Barclays

Events

Earnings calls, analyst events, roadshows and more

AFMD
Today at 16:05

Affimed - AFMD Conference Calls
BRFH
Today at 16:30

Barfresh Food Group - BRFH Conference Calls
Today at 18:05

Fed Reserve Bank President Participates in Virtual Event Government Event

Virtual Event
GHG
Today at 21:00

GreenTree Hospitality - GHG Conference Calls
AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
COO
Tomorrow at 00:00

Cooper Companies - COO Conference Calls
VNRX
Tomorrow at 00:00

VolitionRx - VNRX Conference Calls
VERI
Tomorrow at 00:00

Veritone - VERI Conference Calls
Tomorrow at 00:00

Scrap, Direct Reduced Iron & Mini-Mills 2021 Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	DISCA X DISCA Discovery Block Trade Managers: Credit Suisse Priced at: $38.40 19M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $32.35 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IQ X IQ iQIYI Block Trade Managers: Credit Suisse Priced at: $15.85 35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham Priced at: $30.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $250 Reference Price 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Secondary Managers: SBHS $10.94 45M Shares
Fri	No deals

View All Syndicate Announcements »

Paratek Pharmaceuticals expects cash to fund operations through end of 2023

TODAY'S FREE FLY STORIES

Get Full Fly Access